MENU
NAMS
AS OF
Nov 13, 04:59 PM (EDT)
Price
$36.41
Change
-$1.90 (-4.96%)
Capitalization
4.34B
111 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NAMS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NewAmsterdam Pharma (NAMS) Earnings Date & Reports

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more

A.I. Advisor
published Earnings

NAMS is expected to report earnings to fall 26.05% to -45 cents per share on March 04

NewAmsterdam Pharma NAMS Stock Earnings Reports
Q4'25
Est.
$-0.45
Q3'25
Missed
by $0.21
Q2'25
Beat
by $0.34
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.03
The last earnings report on November 05 showed earnings per share of -61 cents, missing the estimate of -40 cents. With 544.18K shares outstanding, the current market capitalization sits at 4.34B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NAMS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NAMS showed earnings on November 05, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NAMS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Gooimeer 2-35
Phone
+31 352062971
Employees
29
Web
https://www.newamsterdampharma.com